Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Ironwood Pharmaceuticals (IRWD)

Add to Watchlists
Create an Alert
12.00 +0.23  +1.91% NASDAQ Apr 24, 4:59PM BATS Real time Currency in USD
View Full Chart
IRWD Price Chart
View All Events

IRWD Events

Date Type Description
Jan 21 Earnings Ironwood Pharmaceuticals to Host Fourth Quarter Earnings Results. Estimate: -0.50.
Jan 21 Misc Ironwood Pharmaceuticals 4Q2013 Investor Update Conference Call
Jan 21 Misc Ironwood Pharmaceuticals 4Q2013 Investor Update Conference Call
Dec 12 Misc Ironwood Pharmaceuticals Investor Day
Oct 22 Misc Ironwood Pharmaceuticals to Host Third Quarter 2013 Investor Update Call
Oct 22 Earnings Ironwood Pharmaceuticals to Host Third Quarter 2013 Results. Estimate: -0.59.
Jul 23 Misc Ironwood Pharmaceuticals 2Q2013 Investor Update Conference Call
Jul 23 Earnings Ironwood Pharmaceuticals to Host Second Quarter 2013 Investor Update Call. Estimate: -0.71.
View All Performance Charts

IRWD Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ironwood Pharmaceuticals is down 28.41% over the last year vs S&P 500 Total Return up 21.54%, Forest Laboratories up 148.4%, and Synergy Pharmaceuticals up 11.47%.

Get Quote for

PDF Report for IRWD

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download IRWD Pro Report PDF

Portfolio Strategies Featuring IRWD

Did Ironwood Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

IRWD Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Ironwood is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines targeting important therapeutic needs. Its products includes developing Linaclotide, the company's guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation or chronic constipation is currently in Phase 3 clinical development. The company operates its business in one segment: Human therapeutics. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. The company was founded by Peter M. Hecht, Eric F. Summers, Brian M. Cali, Joseph C. Cook, Jr. and Gina Bornino Miller in 1998 and is headquartered in Cambridge, Massachusetts.

Recent Quotes

Symbol Price Chg Chg % Market Cap
IRWD 12.00 +0.23 +1.91% 1.458B
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.